Comparison
11q Partial Monosomy Syndrome C0795841 vs 1p35 2 Microdeletion Syndrome
Clinical comparison between 11q Partial Monosomy Syndrome and 1p35 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
11q Partial Monosomy Syndrome C0795841
0-0
1p35 2 Microdeletion Syndrome
0-null
Onset patterns differ
Severity
11q Partial Monosomy Syndrome C0795841
severe
1p35 2 Microdeletion Syndrome
severe
Different severity levels
Chronic
11q Partial Monosomy Syndrome C0795841
Chronic
1p35 2 Microdeletion Syndrome
Chronic
Differing course
Communicable
11q Partial Monosomy Syndrome C0795841
No
1p35 2 Microdeletion Syndrome
No
Different transmission
Body System
11q Partial Monosomy Syndrome C0795841
congenital
1p35 2 Microdeletion Syndrome
congenital
Same/different system
Category
11q Partial Monosomy Syndrome C0795841
genetic
1p35 2 Microdeletion Syndrome
rare-disease
Different category
Bottom line
11q-partial-monosomy-syndrome-C0795841 and 1p35-2-microdeletion-syndrome-C5679992 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11q Partial Monosomy Syndrome C0795841 | 1p35 2 Microdeletion Syndrome | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as typical, with intellectual disability possible. | Not established from the supplied source. | Moderate |
| Facial differences | Facial differences are described. | Specific facial findings are not supplied. | Low |
| Chromosomal region | Missing material involving chromosome 11q. | Microdeletion involving 1p35.2, extent unspecified. | High |
When to favor each condition
Choose 11q Partial Monosomy Syndrome C0795841 when
Confirmed missing 11q material
The finding matches the named chromosomal region.
High
Developmental delay with facial differences
These features fit the supplied description but are not specific.
Low
Need for supportive developmental care
Care is described as symptom-based and developmental.
Moderate
Choose 1p35 2 Microdeletion Syndrome when
Confirmed 1p35.2 microdeletion
The genomic location distinguishes it from 11q loss.
High
Sparse phenotype data
Do not infer a diagnosis from symptoms not supplied.
High
Uncertain congenital syndrome
Genetic confirmation is needed before assigning this label.
Moderate
How key tests differ
| Test | 11q Partial Monosomy Syndrome C0795841 | 1p35 2 Microdeletion Syndrome | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss involving 11q. | Copy-number loss at 1p35.2. | Location, not symptoms alone, distinguishes the findings. |
| Karyotype | May detect a larger 11q deletion. | A microdeletion may be missed. | A normal karyotype does not exclude either finding. |
| Clinical genetics review | Supports developmental and facial assessment. | Phenotype cannot be defined from these data. | Results require specialist interpretation. |
Prognosis comparison
11q Partial Monosomy Syndrome C0795841
- Outcome
- Long-term outcome is not quantified; developmental needs may persist.
- Factors
- Deletion extent and associated findings may matter, but cutoffs are not supplied.
1p35 2 Microdeletion Syndrome
- Outcome
- Outcome is not established from the supplied data.
- Factors
- Deletion size and clinical findings require specialist review.
Time frame: Congenital and potentially lifelong; exact course is not established.
Neither mortality nor prevalence is supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning needs | Intellectual disability may occur. Learning impact is not established here. Individual assessment is required. |
| Associated anomalies | Not specified beyond facial differences. Not specified in the source. Do not assume organ involvement. |
| Care complexity | May need ongoing developmental support. Support needs are not established. Plan care from confirmed findings. |
Patient education highlights
- HighGenetic confirmation
The chromosomal location must be confirmed before comparing these conditions.
- MediumSupportive care
11q partial monosomy care focuses on symptoms and development; no specific dose is implied.
- LowUncertainty
Available data do not establish the 1p35.2 phenotype or prognosis.